Ben Simon Guy J, Lee Seongmu, Schwarcz Robert M, McCann John D, Goldberg Robert A
Jules Stein Eye Institute and Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Ophthalmology. 2006 Oct;113(10):1869-73. doi: 10.1016/j.ophtha.2006.05.014. Epub 2006 Aug 1.
To compare functional and surgical outcomes of a subperiosteal midface lift with and without the placement of a hard palate mucosal graft (HPMG) in patients with lower eyelid retraction.
Retrospective, comparative, interventional case series.
Thirty-four patients with lower eyelid retractions who underwent surgery at the Jules Stein Eye Institute in a 5-year period.
Medical record review of all patients who underwent surgery for lower eyelid retraction by a subperiosteal midface lift with or without an HPMG. Preoperative and postoperative digital photographs were taken in all patients.
Change in margin reflex distance 2 (MRD2), measured from the pupillary margin to the upper margin of the lower eyelid; patient discomfort; and surgical complications.
Thirty-four patients (20 female; mean age, 64 years) participated in the study; 11 underwent bilateral surgery, with overall 43 surgeries performed. Eighteen patients (42%) had lower eyelid retraction secondary to previous transcutaneous lower eyelid blepharoplasty. Postoperatively, patients attained a better lower eyelid position, with improvement of lower eyelid height of 1.4 mm (P<0.001, 1-sample t test). Patients operated using an HPMG (12 surgeries) achieved a greater reduction in MRD2 postoperatively as compared with patients operated by subperiosteal midface lift alone (31 surgeries; 2.2 mm vs. 1.1 mm, respectively; P = 0.02, Wilcoxon Mann-Whitney). One patient needed reoperation secondary to symptomatic lower eyelid retraction postoperatively.
The subperiosteal midface lift is effective in correction of lower eyelid retraction of various causes. The use of an HPMG spacer may enhance surgical outcomes and results in a better lower eyelid position.
比较在下睑退缩患者中,行或不行硬腭黏膜移植(HPMG)的骨膜下中面部提升术的功能和手术效果。
回顾性、比较性、干预性病例系列研究。
34例在5年期间于朱尔斯·斯坦眼科研究所接受手术的下睑退缩患者。
对所有接受骨膜下中面部提升术治疗下睑退缩的患者进行病历回顾,手术方式包括使用或不使用HPMG。所有患者均拍摄术前和术后数码照片。
从瞳孔边缘到下睑上缘测量的边缘反射距离2(MRD2)的变化;患者不适情况;以及手术并发症。
34例患者(20例女性;平均年龄64岁)参与研究;11例行双侧手术,共进行了43例手术。18例患者(42%)因既往经皮肤下睑成形术导致下睑退缩。术后,患者下睑位置得到改善,下睑高度增加了1.4mm(P<0.001,单样本t检验)。与仅行骨膜下中面部提升术的患者(31例手术)相比,使用HPMG的患者(12例手术)术后MRD2的降低幅度更大(分别为2.2mm和1.1mm;P = 0.02,Wilcoxon Mann-Whitney检验)。1例患者术后因有症状的下睑退缩需要再次手术。
骨膜下中面部提升术对各种原因引起的下睑退缩有效。使用HPMG间隔物可能会提高手术效果,并使下睑位置更好。